Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1625 1628 1629
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18482794 | COCRYSTALS OF UPADACITINIB | Final Rejection | AbbVie Inc. |
| 18712827 | FUNGICIDAL COMPOSITIONS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18558765 | INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCER THERAPEUTICS | Non-Final OA | Board of Regents, The University of Texas System |
| 18291529 | SRPK INHIBITORS | Non-Final OA | Merck Patent GmbH |
| 18285521 | ANTI-ANXIETY COMPOSITION | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 17755556 | ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS | Non-Final OA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy